Axel Cangas/LinkedIn
Jul 19, 2026, 16:58
Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
Axel Cangas, Hematology and Immunology Unit Head at Roche México, shared a post on LinkedIn:
”Thrilled to be at International Society on Thrombosis and Haemostasis (ISTH) 2026 engaging with global experts on the incredible scientific advancements redefining haemophilia care.
It has been inspiring to see Roche’s deep, long-term commitment to this community.
We remain dedicated to standing alongside patients, families, and healthcare professionals for generations to come.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease
-
Sep 3, 2026, 03:51Strengthening Bleeding Disorders Care in New Zealand – WFH
-
Sep 3, 2026, 03:42Nathan Connell: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia